» Authors » Floriano Bonifazi

Floriano Bonifazi

Explore the profile of Floriano Bonifazi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 390
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mei F, Renzi M, Bonifazi M, Bonifazi F, Pepe N, DAllura A, et al.
BMC Pulm Med . 2023 Oct; 23(1):395. PMID: 37853365
Background: Shipping and port-related air pollution has a significant health impact on a global scale. The present study aimed to assess the mortality burden attributable to long-term exposure to ambient...
2.
Bonifazi M, Mei F, Skrami E, Latini L, Amico D, Balestro E, et al.
J Clin Med . 2021 Apr; 10(6). PMID: 33804084
Obesity as well as metabolic and cardiovascular comorbidities are established, significant predictors of worse prognosis in the overall COVID-19 population, but limited information is available on their roles in young...
3.
Rueff F, Przybilla B, Bilo M, Muller U, Scheipl F, Seitz M, et al.
PLoS One . 2013 May; 8(5):e63233. PMID: 23700415
Background: Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Objective: Our aim was to evaluate the association of baseline serum tryptase concentration (BTC)...
4.
Bilo M, Antonicelli L, Bonifazi F
Immunotherapy . 2012 Dec; 4(11):1153-66. PMID: 23194365
The honeybee is an interesting insect because of the fundamental agricultural role it plays, together with the composition of its venom, which presents new diagnostic and immunotherapeutic challenges. This article...
5.
Melioli G, Bonifazi F, Bonini S, Maggi E, Mussap M, Passalacqua G, et al.
Clin Biochem . 2011 Jun; 44(12):1005-11. PMID: 21627961
Objectives: To evaluate the performances of an allergen microarray in multi-sensitized allergic patients with respiratory symptoms. Design And Methods: 321 patients and 92 controls were included in this study. Specific...
6.
Bilo B, Bonifazi F
Immunotherapy . 2011 Feb; 3(2):229-46. PMID: 21322761
Subcutaneous venom immunotherapy is the only effective treatment for patients who experience severe hymenoptera sting-induced allergic reactions, and the treatment also improves health-related quality of life. This article examines advances...
7.
Rueff F, Przybilla B, Bilo M, Muller U, Scheipl F, Aberer W, et al.
J Allergy Clin Immunol . 2010 Jun; 126(1):105-11.e5. PMID: 20542320
Background: Severe side effects during venom immunotherapy (VIT) are associated with a variety of risk factors. Objective: Our aim was to evaluate the association of baseline serum tryptase concentration (BTC)...
8.
Bilo M, Antonicelli L, Bonifazi F
Curr Opin Allergy Clin Immunol . 2010 Apr; 10(4):330-6. PMID: 20410817
Purpose Of Review: Although highly effective, venom immunotherapy (VIT) may be responsible for local and systemic allergic reactions. There is a good theoretical basis for believing that purified aqueous and...
9.
Canonica G, Bousquet J, Casale T, Lockey R, Baena-Cagnani C, Pawankar R, et al.
Allergy . 2010 Jan; 64 Suppl 91:1-59. PMID: 20041860
No abstract available.
10.
Rueff F, Przybilla B, Bilo M, Muller U, Scheipl F, Aberer W, et al.
J Allergy Clin Immunol . 2009 Nov; 124(5):1047-54. PMID: 19895993
Background: Severe anaphylaxis to honeybee or vespid stings is associated with a variety of risk factors, which are poorly defined. Objective: Our aim was to evaluate the association of baseline...